Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Profit Margin (Quarterly): 39.50% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 39.50% |
| Date | Value |
|---|---|
| June 30, 2024 | -53.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-53.80%
Minimum
Jun 2024
39.50%
Maximum
Sep 2024
-7.15%
Average
-7.15%
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Myomo Inc | -10.50% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 98.30% |
| Operating Margin (Quarterly) | 31.61% |